Related Experiment Videos
Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction
Carol A Gunnett1, Donald D Lund, Frank M Faraci
1Department of Internal Medicine, Univ. of Iowa Carver College of Medicine, Iowa City, IA 52242-6778, USA.
Summary
Interleukin-10 (IL-10) protects arteries from inflammatory damage by lipopolysaccharide (LPS). Both systemic and local IL-10 reduce vascular dysfunction and superoxide levels, mitigating effects mediated by inducible nitric oxide synthase (iNOS).
Area of Science:
- Immunology
- Vascular Biology
- Pharmacology
Background:
- Lipopolysaccharide (LPS) induces vascular dysfunction, characterized by impaired arterial relaxation.
- Interleukin-10 (IL-10) is a key anti-inflammatory cytokine with potential protective roles in vascular inflammation.
- Inducible nitric oxide synthase (iNOS) is implicated in inflammatory responses and vascular dysfunction.
Purpose of the Study:
- To investigate the protective effects of systemic and local IL-10 against LPS-induced arterial dysfunction.
- To determine if IL-10 mitigates vascular dysfunction mediated by iNOS following LPS exposure.
- To assess the role of IL-10 in regulating superoxide levels in arteries after LPS challenge.
Main Methods:
- Adenoviral gene transfer was used to deliver IL-10 systemically and locally in IL-10-deficient and wild-type mice.
- Vascular reactivity to acetylcholine was measured in isolated arteries ex vivo.
- Superoxide levels and the role of iNOS (using aminoguanidine and iNOS-deficient mice) were assessed.
Main Results:
- Systemic and local IL-10 gene transfer improved arterial relaxation impaired by LPS.
- LPS increased arterial superoxide levels, which were reduced by IL-10 gene transfer.
- Inhibition of iNOS or absence of iNOS protected against LPS-induced vasomotor dysfunction.
Conclusions:
- Both systemic and local IL-10 protect arteries against LPS-induced inflammatory damage.
- IL-10 reduces vascular dysfunction by decreasing iNOS-mediated impairment of vasorelaxation.
- IL-10 also mitigates LPS-induced increases in arterial superoxide levels.